Vanguard Group’s Climb Bio CLYM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.64M | Sell |
|
|||||
|
2025
Q2 | $1.65M | Sell |
|
|||||
|
2025
Q1 | $1.83M | Sell |
|
|||||
|
2024
Q4 | $2.71M | Sell |
|
|||||
|
2024
Q3 | $7.76M | Buy |
|
|||||
|
2024
Q2 | $2.32M | Buy |
|
|||||
|
2024
Q1 | $851K | Hold |
|
|||||
|
2023
Q4 | $838K | Buy |
|
|||||
|
2023
Q3 | $815K | Buy |
|
|||||
|
2023
Q2 | $769K | Hold |
|
|||||
|
2023
Q1 | $796K | Hold |
|
|||||
|
2022
Q4 | $1.01M | Buy |
|
|||||
|
2022
Q3 | $886K | Hold |
|
|||||
|
2022
Q2 | $829K | Sell |
|
|||||
|
2022
Q1 | $2.56M | Sell |
|
|||||
|
2021
Q4 | $3.2M | Buy |
|
|||||
|
2021
Q3 | $3.59M | Buy |
|